The pharmaceutical sector is seeing a major shift in glucose treatment with the emergence of GLP-1 skin applications. These innovative vehicles offer a possibly simple choice to subcutaneous injections for individuals dealing with diabetes mellitus type 2. By circumventing the requirement for fre